U.S. Army scientists are developing one for – vaccine for coronavirus which will protect from all existing and future mutations virus and are expected to announce the first -encouraging- results of clinical trials in the coming weeks.
“In the coming weeks we will announce the first positive results of clinical trials of the vaccine,” the lead researcher told Defense One, a military news agency, according to Forbes.
The vaccine designed to to deal with possible variations of the coronavirus and, unlike other vaccines against Covid-19, it consists of a protein with 24 different facets, to which scientists can attach pin proteins from other variants that train the immune system to recognize many types of the virus, according to the Americans. researchers.
Early vaccination trials in primates – other than humans – elicited strong antibody responses that protect from original strain causing Covid-19 disease, from its variants as well from other coronaviruses, such as SARS, according to a study published last week in the journal Science Translational Medicine.
The first trials of the vaccine in humans began last April and were performed on volunteers who had not been vaccinated against coronary artery disease and had not become ill.
The super-vaccine can be stored at different temperatureswhich facilitates its worldwide distribution while its ability to protect against other coronaviruses means that it could also to help prevent future viruses, in addition to Covid-19 disease.
The next steps in the development of the super-vaccine include the second and third phases of clinical trials, and the research team will look at how it works in people who have already been vaccinated against Covid-19 or become infected with the virus.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
